NSEOutcome of Board Meeting4d ago · 5 Nov 2026, 11:09 pm

Outcome of Board Meeting

Modi Naturals Limited · MODINATUR

✦ AI SummaryResults

Modi Naturals Limited has submitted its unaudited financial results for the quarter and half year ended September 30, 2026, to the National Stock Exchange of India Limited. The results were approved by the Board of Directors and have been reviewed by the independent auditor B. Chhawchharia & Co. The review report has been submitted to the exchange and will be published in the newspapers as required.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Modi Naturals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

Attachments (1)

📄

MODINATURALS_05112026230832_Final_outcome_sep_qtr.pdf

pdf

Download →
View document text
05th November 2026 The Manager The Manager Corporate Relationship Department Listing Department BSE Limited National Stock Exchange of India Limited First Floor, New Trade Wing Rotunda Exchange Plaza, 5th Floor Plot No. C/1, ‘G’ Block, Building, Phiroze Jeejeebhoy Towers, Bandra- Kurla Complex Bandra, East Mumbai-400 Dalal Street, Fort Mumbai-400001 051 Scrip Code: 519003 Symbol : MODINATUR Dear Sir / Madam, Sub: Outcome of the Board Meeting held on 05.11.2026 Re: Submission of Unaudited Financial Results (Standalone and Consolidated) for the quarter & half Year ended 30th September 2026 Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”), we wish to inform you that the Board of Directors of the Company at its meeting held today, 05th November, 2026, has, inter alia, approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and Half Year ended 30th September, 2026, and took on record the limited review report of the Statutory Auditors of the Company thereon. As required under Regulation 33 of the SEBI LODR Regulations, we enclose herewith the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter & half Year ended 30th September, 2026, along with the limited review report thereon. The said results will be published in the newspapers as required under Regulations 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and will be uploaded on the website of the Company i.e., (www.modinarurals.com) The meeting of the Board of Directors of the Company commenced at 2:00 pm and concluded at 09:45 pm. This is for your kind information and records. Thanking you! Yours Faithfully, for MODI NATURALS LIMITED Akshay Modi Jt. Managing Director DIN:03341142 Encl: as above ‘B.Chhawchharia & Co. DTJ 524 - 525, DLF TOWER B, JASOLA DISTRICT CENTRE, JASOLA, NEW DELHI -110025, INDIA Chartered Accountants TELEFAX (91-11) 4037 8600 ® Web : www.bcco.co.in Independent Auditor’s Review Report on the Quarterly Unaudited Consolidated Financial Results of the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended Review Report to The Board of Directors M/s MODI NATURALS LIMITED 1. We have reviewed the accompanying statement of unaudited consolidated financial results of M/s MODI NATURALS LIMITED(“the Holding Company™) and its subsidiary (the Holding Company and its subsidiary together referred to as “the Group”) for the quarter ended September 30, 2026 being submitted by the Holding Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. }S This statement is the responsibility of the Holding Company’s Management and has been approved by the holding company’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, (IND AS 34) “Interim Financial Reporting™, specified under Section 133 of the Companies Act, 2013 as amended read with relevant rules issues thereunder and other accounting principles generally accepted in India. Our responsibility is to issue a report on these financial statements based on our review. 3. We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410, Review of interim Financial information performed by the Independent Auditors of the entity issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data and thus provides less assurance than an audit. We have not performed an audit and accordingly. we do not express an audit opinion. 4. We also performed procedures in accordance with the SEBI Circular No. CIR/CFD/CMD/44/2019 dated 29th March, 2019 issued by the SEBI under regulation 33(8) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended. to the extent applicable. KOLKATA | NEWDELHI | NAGPUR The Statement includes the results of following entity: Wholly Owned Subsidiary: i. Modi Biotech Private Limited Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement of unaudited financial results prepared in accordance with applicable Indian accounting standards and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulations 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. The review of audited consolidated year-to-date financial results for the period ended March 31, 2026, included in the Statement was carried out and reported by M/s Doogar & Associates, previous auditor who have expressed unmodified conclusion vide their review report, which has been relied upon by us for the purpose of our review of the Statement. Our conclusion is not modified in respect of this matter. The review of unaudited consolidated quarterly and year-to-date financial results for the period ended September 30, 2025 and audit of consolidated financial results for the quarter and year ended March 31, 2026 included in the Statement was carried out and reported by M/s Doogar & Associates, previous auditor who had expressed unmodified conclusion vide their review report and unmodified opinion vide their audit report, respectively, whose reports have been furnished to us and which have been relied upon by us for the purpose of our review of the Statement. Our conclusion is not modified in respect of this matter. For B. Chhawchharia & Co. Chartered Accountants Firm Registration No: 305123E Bopre Abhishek Gupta Partner Membership No.: 529082 Place: New Delhi Date:5™ November, 2026 UDIN: 2.6529082HT)ZW 16629 MODI NATURALS LIMITED Regd. & Corporate Office: D-54, 2nd Floor, Okhla Induatrial Area, Phase-1, New Delhi-110020 (CIN: L15142DL1974PLC007349), Tel: 011-41889999, E-mail: cs.mnl@modinaturals.org, Website: www.modinaturals.com, Statement of Consolidated Unaudited ancial Results for the Quarter and Half Year ended 30-09-2026 PARTI: (X Lakhs, Unless Otherwise Stated) R Quarter Ended Half Year Ended Year Ended 30/09/2026 | 30/06/2026 | 30/09/2025 | 30/09/2026 | 30/09/2025 | 31/03/2026 (Refer Notes Beiow) (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Audited) [ Revenue from Operations 2048995 1570500 1474726 3619495 3034112 7225367 _Other Income 35.84 (3291) 83.57 293 15539 204.12] TotalIncome (1+11)| 2052579 15672.09 14830.83 36197.08| 3049651 72457.79 |@) Cost of materials consumed 1576824 1031996 1000214 2008820 2008464 5271 (b) Purcof hstoack-sin-etrasde 36572 23581 175.97 60153 35723 192410 | |(©) Changes in inventorieosf finished goods. work-in-progreasnds stock-in-trade 5948 317.66 187.41 57714 184202 5658 || @ Bmployee benefis expense i 845.65 851.62 68356 169727 155689 3419.69) (¢) Finance costs 27469 299.44 206.07 57413 483.06 77679 | Selting, Marketing& Distribution Expenses 887.91 664.91 118573 1552.82 200159 4259.82| | |cg) Depreciation and amortisation expense 29141 290.18 20129 58159 40077 80117 |y Other expenses 70111 897.69 70115 159880 123701 263426 s Towlixpenses (V)| 1919421 1407727 1364332 3327148 2796521 66589.98] Profit/ (Loss) before exceptional items and tax (I11-1V) 133158 159482 1187.51 292640] 253130 5867.81 [ W1 Bxceptionalitems 0.00 0.00 0.00 0.00; 0.00/ 485.57 | it [Profitbefore tax (v-v1) 133158 159482 118751 292640 253130 635338 VIl [Tax Expense |@) currentT [Showing first 8,000 characters — download PDF for full document]